SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17675286
Source:
http://linkedlifedata.com/resource/pubmed/id/17675286
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0030705
,
umls-concept:C0045093
,
umls-concept:C0282460
,
umls-concept:C0346976
,
umls-concept:C1521750
pubmed:issue
7
pubmed:dateCreated
2007-8-27
pubmed:abstractText
The objectives of this study were to evaluate the efficacy and toxicity of combination chemotherapy with gemcitabine and cisplatin in patients with metastatic pancreatic cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine
,
http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1465-3621
pubmed:author
pubmed-author:HagiharaAtsushiA
,
pubmed-author:IkedaMasafumiM
,
pubmed-author:MorizaneChigusaC
,
pubmed-author:OguraTakashiT
,
pubmed-author:OkusakaTakujiT
,
pubmed-author:TanakaTsutomuT
,
pubmed-author:UenoHidekiH
pubmed:issnType
Electronic
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
515-20
pubmed:meshHeading
pubmed-meshheading:17675286-Adenocarcinoma
,
pubmed-meshheading:17675286-Adult
,
pubmed-meshheading:17675286-Aged
,
pubmed-meshheading:17675286-Antimetabolites, Antineoplastic
,
pubmed-meshheading:17675286-Antineoplastic Agents
,
pubmed-meshheading:17675286-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:17675286-Cisplatin
,
pubmed-meshheading:17675286-Deoxycytidine
,
pubmed-meshheading:17675286-Disease Progression
,
pubmed-meshheading:17675286-Humans
,
pubmed-meshheading:17675286-Middle Aged
,
pubmed-meshheading:17675286-Neoplasm Metastasis
,
pubmed-meshheading:17675286-Pancreatic Neoplasms
,
pubmed-meshheading:17675286-Survival Rate
,
pubmed-meshheading:17675286-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
pubmed:affiliation
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan. hiueno@ncc.go.jp
pubmed:publicationType
Journal Article
,
Clinical Trial, Phase II